Olopatadine hydrochloride in children: Evidenced efficacy and safety for atopic dermatitis treatment in a randomized, multicenter, double-blind, parallel group comparative study

Nishinihon Journal of Dermatology

Volumn 73, Issue 3, 2011, Pages 278-289

  Kawashima, Makoto ^a   Nakagawa, Hidemi ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

KETOTIFEN FUMARATE; OLOPATADINE;

ADOLESCENT; ANALYSIS OF COVARIANCE; ARTICLE; ATOPIC DERMATITIS; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PARALLEL DESIGN; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCORING SYSTEM; UNSPECIFIED SIDE EFFECT;

EID: 79960785882     PISSN: 03869784     EISSN: None     Source Type: Journal    
DOI: 10.2336/nishinihonhifu.73.278     Document Type: Article

References (9)

1. Okubo K et al: Olopatadine hydrochloride in children: evidenced efficacy and safety for perennial allergic rhinitis in randomized, multicenter, double-blind, placebo-controlled study. Curr Med Res Opin 26: 1657-1665, 2010.